Results 181 to 190 of about 191,459 (192)

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Lancet, The, 2018
Patrick M O'neil, Andreas L Birkenfeld, Barbara Mc Mcgowan   +2 more
exaly  

An Open Letter to Dr. Clarence Cook Little

Ca-A Cancer Journal for Clinicians, 1958
exaly  

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Lancet, The, 1994
exaly  

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

Lancet, The, 2012
exaly  

Opioid analgesics for nociceptive cancer pain: A comprehensive review

Ca-A Cancer Journal for Clinicians
Christina Abdel Shaheed, Chris Hayes, Chris G Maher   +2 more
exaly  

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

Case Medical Research, 2019
openaire   +1 more source

Open Label Placebos In Cancer Related Fatigue: A Systematic Review

International Journal of Gynecological Cancer
Albert Jacob, Adwaith Krishna Surendran, Prasanth Ganesan, M. Rajeswari   +3 more
openaire   +1 more source

DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LUTEINISING-HORMONE- RELEASING-HORMONE NASAL SPRAY IN TREATMENT OF UNDESCENDED TESTES

Lancet, The, 1986
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly  

CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI

Lancet, The, 1988
exaly